Unichem Laboratories Limited (UNICHEMLAB) — Announcement | 10 July 2026
Unichem Laboratories clarified that a recent surge in its share price was purely market-driven with no undisclosed material information, reaffirming compliance with SEBI disclosure norms and stating it will continue timely reporting to exchanges.
About Unichem Laboratories Limited (UNICHEMLAB)
Healthcare · Pharmaceuticals · Listed on NSE
📡 Get AI alerts when UNICHEMLAB files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track UNICHEMLAB — Free💡 Ask AI about this filing
📊 More UNICHEMLAB filings
- 🔴 Announcement — 26 September 2026Unichem Laboratories announced that the USFDA inspected its Goa formulation facility from September ...
- Announcement — 24 September 2026Unichem Laboratories announced that its trading window will close on October 1, 2026, for insiders a...
- 🔴 Announcement — 19 September 2026Unichem Laboratories disclosed on September 19, 2026, that it received an Order-in-Appeal from the C...
- 🟡 Board Meeting — 11 September 2026Unichem Laboratories extended the exercise periods for 75% of vested employee stock options under it...
- 🟡 Board Meeting — 12 August 2026Unichem Laboratories held its 63rd AGM on 11 August 2026 via video conference, where all five resolu...
🔥 Also filed on 10 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when UNICHEMLAB files new disclosures
Track UNICHEMLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track UNICHEMLAB — FreeFree account · 2 AI queries/day